Number of Shares
8,239.00
Current Holdings Value*
â‚©4.82 Mil
% of Portfolio
5.05%
Total Estimate Gain
â‚©28.02 Bil
% of Total Estimate Gain
137.01%

Invesco Emerging Markets Innovators Fund's Samsung BioLogics Co Ltd Holding Summary

As of 2023-04-30, Invesco Emerging Markets Innovators Fund held 8,239.00 shares of Samsung BioLogics Co Ltd(XKRX:207940), totaling â‚©4.82 Mil. This investment constitutes 5.05% of their stock portfolio, and Invesco Emerging Markets Innovators Fund now holds 0.01% of the outstanding Samsung BioLogics Co Ltd(XKRX:207940) stock.

The initial trade took place in 2019Q4. And since then Invesco Emerging Markets Innovators Fund has made 2 purchases of XKRX:207940, at an average price of â‚©320,951.22, for a total of 63,710.00 shares. In addition, there have been 10 sales at an average price of â‚©719,356.18 for 55,471.00 shares. Based on historical transaction data and XKRX:207940's current price of â‚©1039000.00, Invesco Emerging Markets Innovators Fund's estimated gain on his XKRX:207940 holdings is â‚©28.02 Bil, reflecting a 137.01% gain to date.

Invesco Emerging Markets Innovators Fund XKRX:207940 (â‚©1039000.00) Holding Chart

Invesco Emerging Markets Innovators Fund XKRX:207940 (â‚©1039000.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price â‚©-/Share
Shares Sold 0 Average Price â‚©-/Share
Current Price â‚©0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1